Stock A115450 HLB THERAPEUTICS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
8,190 KRW +7.62% Intraday chart for HLB Therapeutics Co.,Ltd. +31.25% +86.77%
Apr. 01 HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI
Mar. 18 HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
HLB Therapeutics Submits Phase 3 Protocol for Neurotrophic Keratopathy
HLB Therapeutics Signs Letter of Intent with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A115450 Stock
  4. News HLB Therapeutics Co.,Ltd.
  5. Other languages